NEWS: SOUTHERN STAR RESEARCH ACCREDITED BY AUSTRALIAN OFFICE OF THE GENE TECHNOLOGY REGULATOR
Southern Star Research, Director Corporate Development, Chris Stellatos said this accreditation is a significant development for the company as biotech demand increases for cell and gene therapy trials. It follows a robust assessment process that has taken more than 3 months.
NEWS: SOUTHERN STAR RESEARCH TO SHARE AUSTRALIA’S BIOTECH BENEFITS AT BIOEUROPE 22
“Supportive rebates, scientific excellence, and rapid approval processes including no requirement for an IND make Australia the stand-out location to conduct clinical trials.”
NEWS: SOUTHERN STAR RESEARCH TO PRESENT AUSTRALIA’S BIOTECH BENEFITS AT OCT, LA JOLLA
Southern Star Research, Director Corporate Development, Chris Stellatos said Australia has positioned itself as the most attractive clinical trial destination.
Why Australia For Clinical Trials?
Why Not? The hardest part about placing your clinical trials in Australia is the decision to consider Australia in the first place. Stepping outside a country you know, to one in another timezone? It’s so much easier to stick with where you know.
Reducing Study Complexity To Minimise Cost And Burden Of Clinical Trials
Reducing Clinical Trial Cost, Complexity & Burden It’s no secret. Clinical trials are getting more complicated and this is driving up the cost of developing new drugs.
Statistical Integrity As An Essential Part Of Adaptive Clinical Trials
Although there are many obstacles that need to be overcome to take an investigational therapeutic successfully through to regulatory approval, the vast majority of issues really come down to two factors – the time and expense associated with clinical trials.
Genome Variations In The Design Of Informed Clinical Trials
Although pharmacogenetics is a relatively new field of study, it has already made a significant contribution to the standard treatment options for several common cancers.
Phase 1 Studies, Efforts to Speed Up Drug Development
Starting a phase 1 trial can be exciting and nerve-racking, especially for First Time in Human studies. In most cases, Phase 1 trials are the first opportunity to assess if the properties of a therapeutic, and its safety in humans at increasing doses, behave as predicted.
Focus On Subject Recruitment
Southern Star Research recognises that a successful trial is always dependent on timely subject recruitment. To achieve this we focus on feasibility, investigator identification, site selection, investigator motivation, advertising and marketing, and patient advocacy groups.
Smooth & Seamless Global Coverage
In addition to our capabilities in Australia, New Zealand and the United Kingdom, Southern Star research has developed a number of alliances with CROs around the world providing experienced clinical trial support for studies conducted across North America, Europe, South America and Asia.